Characteristics of Hearing Loss, Treatment Course and Hearing Outcomes of Streptococcus Suis Meningitis: A Case Series of Four Patients
Year: 2026
Type: article
Abstract: Objective: To describe the characteristics of hearing loss, treatment course and hearing outcomes of patients with hearing loss secondary to Streptococcus suis meningitis. Methods: Design: Retrospective Case SeriesSetting: Tertiary Government Training HospitalParticipants: Four Patients Results: Three patients had microbiologically confirmed Streptococcus suis meningitis based on positive blood or cerebrospinal fluid cultures, while one patient was diagnosed clinically based on compatible clinical manifestations and epidemiologic linkage to contemporaneous culture-confirmed cases. All four patients developed hearing loss during the acute phase of meningitis, ranging from unilateral profound to bilateral severe-to-profound sensorineural hearing loss. Three patients experienced associated vestibular symptoms. All patients received intravenous ceftriaxone and adjunctive intravenous dexamethasone at presentation followed by oral methylprednisolone. Intratympanic dexamethasone (4 mg/mL) was administered after persistent hearing loss despite systemic corticosteroid therapy, with treatment initiated at varying intervals from hearing loss onset. Audiologic outcomes were variable: two patients demonstrated partial improvement in hearing thresholds, whereas two showed minimal or no objective recovery on follow-up pure-tone audiometry. Conclusion: This case series described four patients with Streptococcus suis meningitis who developed early sensorineural hearing loss, ranging from unilateral profound to bilateral severe to-profound hearing loss, often with vestibular symptoms. Despite treatment with antimicrobial therapy, systemic corticosteroids, and adjunctive intratympanic dexamethasone, hearing outcomes were variable, with partial recovery in two patients and persistent severe or profound hearing loss in the other two.
Language: English
Subfield: Neurology
Field: Neuroscience
Domain: Life Sciences
Open Access status: diamond
OpenAlex ID: W7233593701
FWCI:
Cites:
Cited by:
Related to:
